Effect of CTLA4-Ig gene transfer using adenoviral vector in organ and cell transplantation.
Hayashi
S
S
Department of Surgery II, Nagoya University School of Medicine, Japan.
Namii
Y
Y
Kozima
T
T
Kobayashi
T
T
Yokoyama
I
I
Saito
I
I
Hamada
H
H
Ohtsuka
S
S
Uchida
K
K
Takagi
H
H
D000069594:Abatacept; D000256:Adenoviridae; D000818:Animals; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000096:biosynthesis*; D060908:CTLA-4 Antigen; D018014:Gene Transfer Techniques; D017930:Genes, Reporter; D005822:Genetic Vectors; D006084:Graft Rejection / Q000517:prevention & control; D006085:Graft Survival / Q000276:immunology; D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D016031:Liver Transplantation / Q000276:immunology*; D051381:Rats; D011912:Rats, Inbred ACI; D011917:Rats, Inbred Lew; D017208:Rats, Wistar; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis; D013154:Spleen / Q000276:immunology; D014184:Transplantation, Homologous; D001616:beta-Galactosidase / Q000096:biosynthesis
D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D000069594:Abatacept; D001616:beta-Galactosidase